Published on : May 09, 2017
Albany, New York, May 09, 2017: Rapid emergence of new infectious diseases and recent R&D programs by top players in pharmaceutical and biotechnology has positively impacted the anti-infective drugs market in the recent decades. By looking to the driving demand for anti-infective drugs, analysts have prepared a new study on its global market which is entitled as “Global Anti-Infective Drugs Sales Market Report 2017”. This study offers a brief synopsis of the sector and a business outlook on the global market for its benefits. According to the key findings, the global Anti-Infective Drugs market has performed well and also it is expected to reach a high value in (US$) by the end of 2022, growing at an impressive CAGR between 2016 and 2022.
The anti-infective market is an ever-going market and the pharmaceutical sector is having more profit margin than any other sector globally. The anti-infective market is highly fragmented with a large number of domestic and international players. Geographically, the research highlights the major regions including United States, Southeast Asia, China, India, Europe and Japan. For each region, the research covers the details of sales (K MT), revenue (Million USD), market share and growth rate of Anti-Infective Drugs.
The first section of the report covers the market overview of anti-infective drugs along with its scope, market segmentation by type, application and by regions. Anti-infective consists of the drugs that are responsible for killing or inhibiting the growth of a microorganism inside the body. Anti-infectives consists of antibacterials, antivirals, antifungals and others. Among these, antibacterials are preferred as the first line of treatment for a large range of infections. Moreover, on the basis of application; it includes Hospital, Home, Clinic and others. For each segment, this report displays the sales volume, revenue, product price, market share and growth rate for the forecast period of 2017-2022.
As per the findings, the rising prevalence of infectious diseases such as HIV, H1N1 and Ebola virus reflect the profound changes in behavioral patterns of communities over the recent decades. Such infection causing micro-organisms include viruses, bacteria, fungi, viroids and macro parasites. This has created the high, unmet market demand for novel drugs. Also, rapid improvements in healthcare infrastructure coupled with the rising awareness amongst healthcare professionals as well as patients have become another prime factor for the market growth.
Moreover, it has been analyzed that the growing resistance of infection causing organisms to the existing drug therapies could pose a major challenge to the anti-infective market. Additionally, the future market of anti-infectives would be driven by the novel therapeutics which will work against the current antibiotic resistant bacteria.
Click here to get more info with TOC in a PDF Format : http://www.marketresearchhub.com/enquiry.php?type=S&repid=1066814
Top players in the global market are GlaxoSmithKline, Merck, Gilead Sciences, Pfizer, Sanofi-Aventis, Abbott, Wyeth, Roche Pharma AG, Bristol-Myers Squibb, Johnson, Nanosphere, Daiichi Sankyo, Theravance, Sanofi-Aventis, NanoViricides and others.
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-866-997-4948US Toll Free
Email : firstname.lastname@example.org